47 results
DEFM14A
PRTK
Paratek Pharmaceuticals, Inc.
2 Aug 23
Proxy related to merger
5:03pm
equity financing covering the entire purchase
price, including debt repayment and transaction expenses, a “hell or high water” regulatory efforts
PREM14A
PRTK
Paratek Pharmaceuticals, Inc.
30 Jun 23
Preliminary proxy related to merger
9:16am
water” regulatory efforts covenant, and a customary non-solicit provision with a fiduciary out for the Company Board and a Company termination fee of 2.5
425
EX-2.1
9azml 5n34
1 Jul 14
Business combination disclosure
12:00am